Clindamycin-resistant Streptococcus pyogenes in Chinese children
- PMID: 34838224
- PMCID: PMC9760124
- DOI: 10.1016/S1473-3099(21)00699-X
Clindamycin-resistant Streptococcus pyogenes in Chinese children
Conflict of interest statement
We declare no competing interests. This research was funded by the Shenzhen Key Medical Discipline Construction Fund (SZXK032), the Guangdong Medical Research Fund (A2021437), the Hospital Level Project of Shenzhen Children's Hospital (ynkt2020-zz19), and the Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties (SZGSP012). DY and YL contributed equally.
Comment on
-
Increasing clindamycin resistance in group A streptococcus.Lancet Infect Dis. 2021 Sep;21(9):1208-1209. doi: 10.1016/S1473-3099(21)00456-4. Lancet Infect Dis. 2021. PMID: 34450068 No abstract available.
-
Remdesivir, on the road to DisCoVeRy.Lancet Infect Dis. 2022 Feb;22(2):153-155. doi: 10.1016/S1473-3099(21)00559-4. Epub 2021 Sep 14. Lancet Infect Dis. 2022. PMID: 34534513 Free PMC article. No abstract available.
References
-
- White BP, Siegrist EA. Increasing clindamycin resistance in group A streptococcus. Lancet Infect Dis. 2021;21:1208–1209. - PubMed
-
- Hsia Y, Lee BR, Versporten A, et al. Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries. Lancet Glob Health. 2019;7:e861–e871. - PubMed
-
- Isogai N, Urushibara N, Kawaguchiya M, et al. Characterization of Enterococcus faecium with macrolide resistance and reduced susceptibility to quinupristin/dalfopristin in a Japanese hospital: detection of extensive diversity in erm(B)-regulator regions. Microb Drug Resist. 2013;19:298–307. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
